Sage Therapeutics Inc (SAGE)
5.48
+0.04
(+0.74%)
USD |
NASDAQ |
Dec 24, 16:00
Sage Therapeutics Research and Development Expense (Quarterly): 54.58M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Outset Medical Inc | 8.139M |
| Biogen Inc | 542.70M |
| Johnson & Johnson | 4.952B |
| Lifecore Biomedical Inc | 2.186M |
| Poseida Therapeutics Inc | 41.91M |